ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2
暂无分享,去创建一个
A. Chaudhry | M. Ufkin | H. Prince | J. Walewski | S. Ambati | T. Tan | I. Jarque | C. Carpio | T. Kim | W. Kim | S. Ayyappan | F. Lim | E. Iskierka-Jażdżewska | J. Li | S. Cho | S. Oh | H. Mohamed | M. Zhu | M. Poon | A. Gutiérrez